Elsevier Launches New Open Access Journal: Applied and Translational Genomics
Amsterdam, July 30, 2012 – Elsevier, a world-leading provider of scientific, technical and medical information products and services, announces the launch of Applied and Translational Genomics, an open access journal. The journal is dedicated to publishing articles on applied genomics and translational research.
The completion of the human genome project gave way to research that takes the genetic code and applies it to research that aims to eradicate disease. This applied genomic research is most relevant in the area of translational research, or, the field of research which finds itself between that of basic research and clinical trials. Applied and Translational Genomics serves as a home for this exponentially expanding field of research.
“Like any other scientific and technological field, an important outcome measure of research is its meeting societal expectations in wide ranging domains including economic gains, improving living standards, compatible with socio-cultural and religious practices, keeping consistent with contemporary ethical, moral and legal requirements,” said Dhavendra Kumar, MD, Editor-in-Chief of the journal. “There are several potential areas where rapid advances in scientific understanding and avenues for translational research seriously need to be considered. Applied and Translational Genomics aims to be the premier journal to publish this cutting-edge research.”
Bart Wacek, Executive Publisher Life Sciences at Elsevier added, “We are delighted that we have been able to launch this journal in this important area of scientific research. Applied and Translational Genomics has a broad scope and provides a home for high quality research in the areas that sometimes get caught in between basic research and clinical trials.”
For more information or to submit and article, go to: Applied and Translational Genomics. First articles to be published in the journal are now available through ScienceDirect.
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com
Gwen van der Heide
+ 31 20 485 2594